Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 18, 2000

View Archived Issues

Crucell Plans Dual IPO Following Merger Of IntroGene, U-BiSys

Crystal Structure Of DNA Repair Protein May Hold Cancer Clues

UK First Country To Allow Use Of Genetic Testing By Insurers

Genetix Aims To Raise #27M To Boost Sales Force, R&D

Diatos Raises $13M To Fund Cancer, Infection Programs

Bosentan Gains Orphan Status In Pulmonary Hypertension

Cooperative EU-U.S. Biotech Effort Lauded At 10-Year Mark

Transghne, Mirus Collaborate On Gene Transfer Technology

GenOdyssee Attains Genotyping Objective, Plans To Lower Price

Alizyme Sees Positive Results In Phase IIa Study Of Drug For IBS

New Chairman, Secretary General Settle Into EuropaBio Positions

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...